RIFAXIMIN
Clinical trials for RIFAXIMIN explained in plain language.
Never miss a new study
Get alerted when new RIFAXIMIN trials appear
Sign up with your email to follow new studies for RIFAXIMIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria tweak may boost heart drug power
Disease control Not yet recruitingThis study looks at whether an antibiotic called rifaximin can help the blood thinner ticagrelor work better in people who have had a heart attack or unstable angina. The idea is that unhealthy gut bacteria might make the drug less effective. The study will involve 50 adults who …
Matched conditions: RIFAXIMIN
Phase: PHASE4 • Sponsor: Collegium Medicum w Bydgoszczy • Aim: Disease control
Last updated May 26, 2026 12:10 UTC
-
New hope for bloating sufferers: antibiotic rifaximin under trial
Symptom relief Not yet recruitingThis study tests whether a 14-day course of the antibiotic rifaximin can reduce bothersome bloating in adults with irritable bowel syndrome, functional constipation, or functional abdominal bloating. About 78 participants will receive either rifaximin or a placebo, and researcher…
Matched conditions: RIFAXIMIN
Phase: PHASE3 • Sponsor: Mahidol University • Aim: Symptom relief
Last updated May 26, 2026 11:59 UTC